Foxconn Deploys AI Systems Across Taiwan Hospitals

Why It Matters

The AI rollout expands workforce capacity and improves care quality in a rapidly aging society, positioning Taiwan as a blueprint for national, regulated health‑AI deployment.

Key Takeaways

• Foxconn’s CoDoctor platform uses NVIDIA Nemotron models for diagnostics
• Nurabot robot cuts logistics time by up to three hours daily
• Digital twins reduce AI deployment time 40% and achieve 98% navigation accuracy
• Healthy Taiwan initiative allocates $1.5 B for regulated health‑AI ecosystem
• AI tools now active in nine hospitals serving over 14 M patient encounters

Pulse Analysis

Taiwan’s demographic shift toward an older population is straining its healthcare system, prompting a strategic pivot to AI‑enhanced operations. By leveraging NVIDIA’s open‑weight Nemotron models, Foxconn’s CoDoctor platform delivers real‑time diagnostic support across cardiology, oncology and ophthalmology, allowing clinicians to focus on decision‑making rather than data entry. This digital‑first approach aligns with the Healthy Taiwan initiative’s goal of creating a unified, regulated AI ecosystem, supported by a $1.5 billion government commitment.

Beyond software, Foxconn is deploying physical AI agents that work side‑by‑side with medical staff. The Nurabot nursing robot automates transport and logistics, freeing nurses for direct patient care, while the Scrub Bot assists surgeons through voice‑controlled actions in the operating room. These agents are orchestrated through the CoDoClaw interface, which unifies disparate AI tools under a single clinical workflow, enhancing coordination and reducing procedural bottlenecks.

A key differentiator is Foxconn’s use of NVIDIA Omniverse to create digital twins of hospital environments. Simulated testing accelerates rollout, slashing deployment timelines by 40% and delivering 98% navigation precision for autonomous robots. The success across nine major hospitals—handling more than 14 million patient encounters annually—offers a replicable model for other nations seeking to embed AI within regulated health frameworks while maintaining safety and efficacy.